United States · FDA National Drug Code directory
gemcitabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-235_595a8cf5-412a-482d-8d77-979741ee4912
- Product NDC
- 25021-235
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- gemcitabine hydrochloride
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141229
- Source listing expiry
- 20261231
Source-listed ingredients
- GEMCITABINE HYDROCHLORIDE — 1 g/25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (25021-235-50) / 25 mL in 1 VIAL · 25021-235-50
- 10 VIAL in 1 CARTON (25021-235-51) / 25 mL in 1 VIAL · 25021-235-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →